This “Natural” Injection Promises Pain Relief, Hair Growth, and More. But Does It Work And Is It Safe?

Doctors share everything to know about the buzzy treatment.
Rams Wire

Michigan man gets new Roctavian gene therapy for hemophilia A

Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene ...

Michigan man gets gene therapy for hemophilia A outside clinical trials

The patient, who is in his 30s, got the one-time intravenous infusion at the Infusion and Chemotherapy Treatment Center at Henry Ford Cancer-Detroit.
Medscape

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.